University of Missouri School of Medicine, Roche collaborate on first US implementation of tumor board software that improves treatment decision process for cancer patients

Published on by Press Releases

COLUMBIA, Mo. — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the result of a collaboration with the University of Missouri School of Medicine (MU School of Medicine) to implement—for the first time in the U.S.—Roche’s new software solution to streamline and standardize the management of tumor boards, or multi-disciplinary meetings oncology care teams hold to make clinical treatment decisions for cancer patients.

Roche Logo (PRNewsfoto/Roche)

Managing tumor boards can be labor intensive and time consuming for healthcare providers because it often requires manually collecting and organizing patient information from various sources—radiology and microscope slide images, pathology reports, electronic medical records and much more. “Our goal in working on this pilot with the MU School of Medicine and clinicians at MU Health Care was to fine-tune a digital decision support tool that could help transform the tumor board process,” said Alan Wright, MD, MPH, chief medical officer for Roche Diagnostics Corporation. “The collaboration gave us the opportunity to improve the software in a way that would fundamentally change the way their oncology care teams prepare for, conduct and document clinical treatment decisions for cancer patients.”

The new NAVIFY Tumor Board solution is designed to streamline and standardize tumor board workflows by combining relevant patient data from disparate sources into a cloud-based workflow solution and dashboard that facilitate efficient team collaboration, reduce errors, and give the care team more time to evaluate potential treatment options.

In addition to piloting the software for Roche and providing extensive feedback in the development process, MU Health Care has now used the newly launched commercial version of the software for actual tumor boards with two of its nine oncology care teams, and plans to implement the software across all of the remaining teams in the near future.

“As an academic health center, one of our goals is to bring innovation and discovery to the field of medicine,” said Jerry Parker, PhD, associate dean for research at the MU School of Medicine. “With our partners at Roche, we’ve only begun to explore the possibilities, but we already see tremendous potential for this type of solution to help advance cancer care. The workflow is much easier for our oncology nursing staff to manage, and the patient information is presented much more clearly, so we expect that to improve efficiency in the meetings and create more time for in-depth discussion of patient cases and the best treatment options.”

The software is designed to create a centralized repository of tumor board data, which will eventually enable MU Health Care providers and other oncology care teams to see how similar patients were managed in the past, and allows remote participation of experts from outside the location during the meeting, facilitating the concept of virtual tumor boards.

“There is the opportunity for a software solution like this to expand access to tumor boards in smaller communities,” added Dr. Parker. “It’s estimated that less than 50 percent of cancer patients in the U.S. benefit from tumor boards, in part because many communities are not in close proximity to oncology providers. I can foresee a day when a small community provider or hospital will be able to upload data to a regional cancer center tumor board to get access to highly specialized advice regarding their patients—or participate in tumor boards themselves remotely. There is exciting potential there to expand quality healthcare for cancer patients regardless of their location.”

About the NAVIFY portfolio
The NAVIFY brand represents Roche’s commitment to provide healthcare professionals with digital workflow and decision support solutions that transform patient care. The first commercially available product in the portfolio is the NAVIFY Tumor Board solution, a comprehensive dashboard for oncology care teams that enables them to standardize preparation, streamline presentation and ensure a more efficient workflow for individualized treatment decisions. The software is built and hosted on a secure cloud platform that is HIPAA compliant to ensure patient data security and privacy.

The portfolio will continuously evolve to include additional decision support applications and workflow products that address challenges faced by healthcare providers and research professionals. For more information, visit www.navify.com.

About the MU School of Medicine
The MU School of Medicine has improved health, education and research in Missouri and beyond for more than 170 years. MU physicians treat patients from every county in the state, and more Missouri physicians received their medical degrees from MU than from any other university. The MU School of Medicine is home to research and educational programs in biomedical, clinical and translational sciences focused on translating discoveries into community-based products, services and practices for the state and nation. Research efforts concentrate on the deadliest diseases, such as cancer and cardiovascular disease, and the most vulnerable patients, including children and the elderly. For more information, visit http://medicine.missouri.edu/.

About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognized as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry nine years in a row by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com or usdiagnostics.roche.com.

126 thoughts on “University of Missouri School of Medicine, Roche collaborate on first US implementation of tumor board software that improves treatment decision process for cancer patients”

  26. I’ve been having issues with my Windows hosting. It has set me back quite a bit while making the next list. This is the current list that I have. I should add another list in less than a week. I’ll let you all know when the next list is ready. Thank you for your patience.

  42. Good info! Interesting info over this website. It’s pretty worth enough for me. In my view, if all web owners and bloggers made good content as you did, the web will be much more useful than ever before. I couldn’t refrain from commenting. I’ve spent 1 hour trying to find such tips. I’ll also share it with a couple of friends interested in it. I have just bookmarked this website. Now with the work done, I going to visit some live sexy hot gay cams. Thank you!! Greetings from Miami!

  44. I ddo not know whether it’s just me or if everybody else encountering issues with your website.
    It appears as if some of the wrtitten text on your content aare running off
    the screen. Can sopmebody else please comment and let me know if this
    is happening tto them too? This may be a issue with myy internet browser because I’ve had this happen before.
    Many thanks

  47. There’s nothing hotter in this entire world than seeing two girls make sweet love. Seeing a girl face deep in pussy is a dream come true. Dreams have a way of turning into reality at https://t.frtyt.com/ekuezzm5kw?aff_id=29696&offer_id=5407&nopop=1 This site is dedicated to stepsisters who love to lick and finger each other. You always knew stepsisters did this sort of thing with each other. You just never seen it with your own eyes until now!

  54. Are you sick and tired of being lonely? Why should you not have someone special in your life? Everyone deserves to find love. You can find that and a whole lot more at https://t.irtyc.com/avekqggwlc?aff_id=29696&offer_id=3785&bo=2753,2754,2755,2756 This is one of those sites where it’s super easy to hook up. You’ll meet all kinds of girls. Don’t sit on the couch and hang out online all night. Hook up with a chick and have yourself a little fun. Every guy deserves to have a gal in his life. What are you waiting on?! Connect with a cutie today and put a smile all over your face.

  60. Good info! Interesting informations over this website. It is pretty worth enough for me. Personally, if all webmasters and bloggers made good content as you did, the web will be much more useful than ever before. I could not refrain from commenting. I ‘ve spent some hours searching for such article. I’ll also share it with a couple of friends interested in it. I have just bookmarked this website. Finished with the job done, I will visit some model trans cams. Danke!! Greetings from Indianapolis!

  61. Are you the type of guy who likes to look at fat girls naked? If so, then https://t.frtyh.com/755v8haio0?aff_id=29696&offer_id=5331&bo=2753,2754,2755,2756 is the site you’ve been searching for. It’s full of nothing but sexy fat women. These big beautiful women are exactly what your eyeballs have been begging to see. Don’t be surprised if you pop a boner while looking at these hefty honeys. They’re full of curves and are exactly what your penis likes.

  64. CLINIQUE 倩碧線上購物官網。瀏覽Clinique倩碧官方網站，了解更多線上購物、護膚、彩粧、香氛及禮品詳情。通過過敏性測試，百分百不含香料。

  66. 除皺特點 純度高，效果好 見效迅速，無創無痛 安全精準，表情自然 唯一在臨床有20多年的注射材料，全球超過11000000人使用 適用範圍 魚尾紋、額頭紋、眉間紋、鼻紋和頸部皺紋都可以祛除； 最適合於早期的、不太明顯的皺紋 不須使用任何的鎮靜劑或局部麻醉劑，且Botox除皺治療後可立即繼續進行正常的活動。 Botox除皺可以利用午休時間約診即可，完全不影響工作的安排。BOTOX肉毒桿菌素是一種高度純化的蛋白質，經過注射之後，能夠使導致動態皺紋的肌肉得到放鬆，它能夠阻斷導致肌肉收縮的神經細胞，使面部線條變得平滑並防止新皺紋形成。全球銷量第一品牌 在中國唯一獲得SFDA、FDA批准用於醫療美容的肉毒桿菌素 唯一一個擁有40年安全記錄的肉毒桿菌素 在70個國家獲得批准使用 BOTOX肉毒杆菌素

  68. I precisely wished to thank you very much again. I do not know the things I might have implemented without the suggestions shared by you concerning such a subject. Certainly was a difficult scenario for me, however , noticing the skilled strategy you treated it made me to jump for happiness. I am just happy for this work and then pray you know what an amazing job you were undertaking teaching others all through a web site. Most likely you have never come across any of us.

  70. I was pretty pleased to find this great site. I need to to thank you for your time for thhis
    particularly wonderful read!! I definitely loved every littrle biit oof iit and I have you saved as a favorite tto check oout new
    stuff on yoyr website.

  74. 韓國膠原蛋白提拉線，在韓國又稱作FTL(Fine Thread Lifting細線埋入拉提術)」，可達到最新趨勢V臉回春效果。它是運用獲得韓國食品藥品管理局KFDA最高安全等級認證的可吸收縫線PDO (polydioxanone)的Fine Thread(細螺紋) 埋入皮膚真皮層裡作用，利用異物反應原理，促進皮膚真皮膠原的增生、刺激局部微循環、從而提拉皮膚和肌肉，增強皮膚彈性，達到提升、除皺，美白、嫩膚等多重回春效果。

  75. Hello there, I found your website bby the use of Google at the same time as looking
    for a comparable subject, your website got here up, iit appears to be like great.
    I’ve bookmarked it in my google bookmarks.
    Hi there, just was alert to your weblog thru Google, and located that
    it’s truly informative. I’m going to watch oout for brussels.

    I’ll apprecjate should you contijue this in future. Many folks
    will likely bbe benefited fom your writing.

    Cheers!

  76. Heya i’m for the first time here. I came across this board and I
    find It truly useful & it helped me out a lot.
    I am hoping to offer something back and aid others such
    as you aided me.

  78. Thanks , I have just been looking for information about this topic for a while and yours is the greatest
    I’ve came upon so far. But, what about the conclusion? Are you positive concerning the supply?

  80. You could definitely see your enthusiasm in the work you write.
    The arena hopes for more passionate writers such as you who are
    not afraid to say how they believe. At all times follow your
    heart.

  82. Thank you for the good writeup. It in fact was a amusement account it.
    Look advanced to far added agreeable from you! By the way,
    how could we communicate?

  83. An outstanding share! I’ve just forwarded
    this onto a friend who had been doing a little homework on this.
    And he in fact bought me breakfast due to the fact that I found it for him…
    lol. So let me reword this…. Thanks for the meal!!
    But yeah, thanks for spending time to talk about this subject here on your web site.

  85. Hi, I read your University of Missouri School of Medicine, Roche collaborate on first US implementation of tumor board software that improves treatment decision process for cancer patients – Clayton Times blogs daily. Your writing style is awesome, keep it up! Poker https://goo.gl/qE4J53

  87. Hey would you mind sharing which blog platform you’re working with?
    I’m going to start my own blog in the near future but I’m having
    a tough time deciding between BlogEngine/Wordpress/B2evolution and
    Drupal. The reason I ask is because your design seems different then most blogs and I’m looking for something
    completely unique. P.S Apologies for being
    off-topic but I had to ask!

  88. Hi there! This post couldn’t be written any better!

    Looking through this post reminds me of my previous roommate!

    He continually kept talking about this. I most certainly will
    forward this article to him. Fairly certain he’ll have
    a very good read. Many thanks for sharing!

  89. I ddo believe all of the ideas you have introduced on your post.
    They’re very convincing and will definitely work.
    Nonetheless, the posts are too quick for newbies. May just you please lengthen them
    a bit from next time? Thank you for the post.

  91. Good article! Amazing tips over this web. It is pretty worth enough for me. In my view, if all web owners and bloggers made good content as you did, the Inet will be a lot more helpful than ever before. I couldn’t resist commenting. I have spent some time searching for such infos. I’ll also share it with a couple of friends interested in it. I’ve just bookmarked this website. Now with the job done, I will watch some free live babe cams. Gracias!! Greetings from Davenport!

  105. Great blog right here! Also your website rather a lot up fast!
    What web host are you the use of? Can I get your associate link in your host?
    I desire my website loaded up as quickly as yours lol

  109. HiHelloHi thereHello thereHowdyGreetings, I thinkI believeI do believeI do thinkThere’s no doubt that your siteyour websiteyour web siteyour blog might bemay becould becould possibly be having browserinternet browserweb browser compatibility issuesproblems. When IWhenever I look at yourtake a look at your websiteweb sitesiteblog in Safari, it looks fine but whenhowever whenhowever, ifhowever, when opening in Internet ExplorerIEI.E., it hasit’s got some overlapping issues. I justI simplyI merely wanted to give you aprovide you with a quick heads up! Other than thatApart from thatBesides thatAside from that, fantasticwonderfulgreatexcellent blogwebsitesite!

  115. naturally like your web-site buut you need to test the spelling on quite a few
    oof your posts. A number of them are ride
    with spelling problems and I in findiung it very bothersome to tell the reality
    nevertheless I’ll surely come back again.

  118. I would like toI mustI’d like toI have to thank you for the efforts you haveyou’ve put in writing thispenning this blogwebsitesite. I am hopingI’m hopingI really hope to seeto viewto check out the same high-grade blog postscontent from youby you in the futurelater on as well. In factIn truth, your creative writing abilities has inspiredmotivatedencouraged me to get my ownmy very ownmy own, personal blogwebsitesite now 😉

  121. First of all I want to say wonderful blog! I had a quick question that I’d like to ask if you don’t mind.
    I was interested to know how you center yourself and clear
    your head before writing. I’ve had difficulty clearing my thoughts in getting my
    ideas out there. I truly do enjoy writing however it just seems
    like the first 10 to 15 minutes tend to be wasted just trying to figure out how to begin. Any recommendations or
    tips? Many thanks!

  122. I’mimpressed, I must say. Seldom do I come across a blog that’s equally educative and engaging, and without a
    doubt, you’ve hit the nail on tthe head. The issue is an issue tat not enough men and women are speaking intelligently about.
    Now i’m very happy that I came across this during my
    hunt for something concerning this.

  123. HiWhat’s upHi thereHello i am kavin, its my first timeoccasion to commenting anywhereanyplace, when i read this articlepostpiece of writingparagraph i thought i could also makecreate comment due to this brilliantsensiblegood articlepostpiece of writingparagraph.

  126. HelloHeyHi there, You haveYou’ve performeddone a greatan excellenta fantastican incredible job. I willI’ll definitelycertainly digg it and for my partpersonallyindividuallyin my opinionin my view recommendsuggest to my friends. I amI’m sureconfident they willthey’ll be benefited from this siteweb sitewebsite.

Leave a Reply

Your email address will not be published.